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ABSTRACT  
This study was conducted in order to determine the susceptibility of Enterococcus faecalis to the antibiotics penicillin, erythromycin, 
tetracycline, chloramphenicol and gentamicin through measuring the zone of inhibition. The susceptible, intermediate and resistant categories 
were assigned on the basis of the critical points recommended by the Clinical and Laboratory Standards Institute. E. faecalis was susceptible to 
tetracycline as low as 20 μg/20 μl. Starting at a dose of 60 μg/20 μl and 200 μg/20 μl, the bacterium was susceptible to penicillin and 
erythromycin, respectively. The bacterium was resistant to chloramphenicol even at the highest dosage of 400 μg/20 μl. Meanwh ile, from 5 to 
100 μg/20 μl, the bacterium was resistant to gentamicin and the classification was changed into intermediate starting at 200 μg/20 μl.  
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INTRODUCTION 
Enterococci are Gram-positive, catalase-negative, non-spore 
forming and facultative anaerobic bacteria that can occur 
either as single cocci or in chains1. Enterococci are 
considered commensals of the gastrointestinal tract of a 
variety of organisms, including humans. They are found in a 
number of environments, due to dissemination in animal 
excrement and environmental persistence2. Enterococci are 
originally defined by Shernan3 as hardy microorganisms that 
can withstand harsh conditions such as growth at 10 °C up to 
45 °C, at pH 9.6, in 6.5 % NaCl broth and 40 % bile salts, and 
survive at 60 °C for 30 minutes. Starving Enterococcus 
faecalis maintain their viability for extended periods and 
become resistant to UV irradiation, heat, sodium 
hypochlorite, hydrogen peroxide, ethanol and acid4. 
The origins of Enterococcus spp. vary from environmental to 
animal and human resources1. Enterococci are essential part 
of the microflora of both humans and animals. The numbers 
of E. faecalis in human feces range from 105 to 107 per gram, 
and 104 to 10 5 for E. faecium. The isolation of E. faecium and 
E. faecalis is less prevalent from livestock than from human 
feces5. 
Many factors are attributed to the virulence of Enterococcus 
spp.  such as (1) ability to colonize the gastrointestinal tract, 
which is the normal habitat; (2) ability to adhere to a  
 
range of extracellular matrix proteins, including 
thrombospondin, lactoferrin and vitronectin; and (3) ability 
to adhere to urinary tract epithelia, oral cavity epithelia and 
human embryo kidney cells5.  Most infection is thought to be 
endogenous, by translocation of the bacteria through the 
epithelial cells of the intestine, which then cause infection via 
lymph nodes and thus spread to other cells within the body5. 
The ability of enterococci to acquire new resistance genes 
imported on plasmids, transposons and conjugative 
transposons is alarming, especially if these resistances are 
associated with the pathogenicity. The antibiotic resistance 
of Enterococcus is well documented6. Enterococcus spp. may 
show resistance to glycopeptides such as vancomycin, 
teipclopanin and aminoglycosides6. It has been reported that 
if glycopeptide resistant enterococci are present in an 
infected animal rather than an antibiotic-susceptible strain, 
clinical treatment failure is increased by 20% and mortality 
is increased by 27 to 57%7. When assessing the studies on 
enterococcal antibiotic resistance, the pattern that is 
emerging is the possible occurrence of multidrug resistant 
strains8. 
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MATERIALS AND METHODS 
Source and Maintenance of E. faecalis 
Pure culture of E. faecalis was obtained from the Fish 
Pathology Laboratory of the College of Fisheries in Central 
Luzon State University, Philippines. The identity of the 
isolate was confirmed by 16s rRNA sequencing. The isolate 
was maintained in Trypticase Soy Agar (TSA) with mineral 
oil under room temperature.  
Preparation of Filter Paper Discs 
Approximately 6 mm holes were made in Whatman filter 
paper No. 3 using a puncher. The filter paper discs were 
autoclaved at 15 lbs pressure for 30 minutes.  
Preparation of Antibiotic Stock Solution 
Powdered form of ampicillin was purchased in drugstores. In 
order to obtain a stock solution of 20 μg/μl, a known weight 
of the antibiotics was dissolved in sterile distilled water. The 
stock solution was diluted at the time of disc preparation to 
obtain the working solution of 10 mL. The concentrations of 
antibiotics solutions that were evaluated are presented in 
Table 1. Using a micropipette, a fixed volume of 20 μl was 
loaded on each disc one by one. 
Drying and Impregnation of Discs 
The antibiotic discs were allowed to dry in a clean incubator 
at 37 °C for 4 hours. Meanwhile, about 2 to 3 colonies of 18 to 
24-hour bacterium were suspended in Trypticase Soy Broth 
(TSB). The tube was incubated at 37 °C for 1 to 2 hours. The 
bacterial suspension was adjusted to 0.5 McFarland turbidity 
standards and was evenly spread in TSA plates using a sterile 
cotton swab. After the inoculum has dried, the prepared 
antibiotic discs were placed on the surface of the inoculated 
plate using sterile forceps. The plates with discs were 
incubated at 37 °C and were observed after 18, 24 and 48 
hours of incubation. The diameter of the zone of inhibition 
was measured in millimeters using ruler. The susceptible, 
intermediate and resistant categories were assigned on the 
basis of the critical points recommended by the Clinical and 
Laboratory Standards Institute9. 
 
 
 
Table 1: Computed volume of stock solution in each concentration of working solution 
Concentration of 
Stock Solution  
(μg/μl) 
Volume of Stock 
Solution             
(mL) 
Concentration of 
Working Solution 
(μg/20 μl) 
Volume of Working 
Solution                    
(mL) 
20 0.00 0 10 
20 0.13 5 10 
20 0.25 10 10 
20 0.50 20 10 
20 1.00 40 10 
20 1.50 60 10 
20 2.00 80 10 
20 2.50 100 10 
20 5.00 200 10 
20 10.00 400 10 
 
 
RESULTS AND DISCUSSION  
Susceptibility Profiles of E. faecalis 
The susceptibility profiles expressed as zone of inhibition 
(ZOI) of E. faealis on the various dosages of antibiotics are 
presented in Table 2. As a general trend, the susceptibility of 
the bacterium increases along with the dosages of the 
antibiotics. From a dose of 5 μg/20 μL until the highest dose 
of 400 μg/20 μL, the ZOIs of tetracycline were significantly 
higher as compared to penicillin, erythromycin, 
chloramphenicol and gentamicin. The best antibiotic for the 
treatment of E. faecalis in Nile tilapia was tetracycline based 
on the result of this present study. Except for tetracycline, 
the ZOIs of penicillin at 10, 60, 80 and 100 μg/20 μL were 
significantly higher as compared to erythromycin, 
chloramphenicol and gentamicin, thus, these antibiotics were 
the second choices for treating tilapia infected by E. faecalis. 
The antibiotic that ranked third based on the diameter of 
ZOIs was erythromycin, with ZOIs that were significantly 
higher to chloramphenicol from 20 to 400 μg/20 μL and to 
gentamicin at 10 μg/20 μL and from 40 to 400 μg/20 μL. The 
last two antibiotics that had the smallest recorded ZOIs were 
chloramphenicol and gentamicin.  
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Table 2: Susceptibility profiles of E. faecalis on the various dosages of antibiotics 
Dosages 
(μg/20 μL) 
Zone of Inhibition (mm) 
Penicillin Erythromycin Tetracycline Chloramphenicol Gentamicin 
0 6.00±0.00a 6.00±0.00a 6.00±0.00a 6.00±0.00a 6.00±0.00a 
5 7.67±0.52b 8.00±0.00b 22.92±2.54a 7.17±0.41b 8.83±0.26b 
10 9.83±0.75b 7.17±0.41c 23.83±1.83a 7.25±0.61c 11.50±0.45b 
20 15.17±1.47b 14.25±1.04b 24.92±0.20a 7.00±0.00c 12.58±0.38b 
40 17.08±1.80b 18.08±1.43b 26.75±1.33a 7.17±0.41d 12.50±0.45c 
60 20.25±0.52b 16.33±0.88c 26.33±0.98a 6.17±0.26e 12.50±0.45d 
80 20.75±0.42b 17.33±1.72c 30.92±0.58a 7.25±0.61e 13.67±0.82d 
100 20.75±0.42b 17.67±0.88c 31.25±2.34a 6.67±0.52e 14.50±0.45d 
200 22.92±0.92b 20.08±1.20b 30.25±0.27a 7.00±0.00d 16.00±0.55c 
400 22.42±1.88b 20.58±0.92b 30.25±1.04a 6.33±0.52d 16.92±0.49c 
Means (±SD) not sharing a common superscript between columns are significantly different (p<0.05) 
 
Based on CLSI9, the bacterium E. faecalis was susceptible to 
tetracycline as low as 20 μg/20 μl. Starting at a dose of 60 
μg/20 μl and 200 μg/20 μl, the bacterium was susceptible to 
penicillin and erythromycin, respectively. The bacterium 
was resistant to chloramphenicol even at the highest dosage 
of 400 μg/20 μl. Meanwhile, from 5 to 100 μg/20 μl, the 
bacterium was resistant to gentamicin and the classification 
was changed into intermediate starting at 200 μg/20 μl 
(Table 3).  
   
Table 3: CLSI classifications of E. faecalis on the various dosages of antibiotics 
Dosages 
(μg/20 μL) 
CLSI Classification 
Penicillin Erythromycin Tetracycline Chloramphenicol Gentamicin 
0 -- -- -- -- -- 
5 R R S R R 
10 R R S R R 
20 I R S R R 
40 I I S R R 
60 S I S R R 
80 S I S R R 
100 S I S R R 
200 S S S R I 
400 S S S R I 
     Note: Resistant (R) = < 14 mm; Intermediate (I) = 15 to 19 mm; Susceptible (S) = > 20 mm 
 
Tetracycline is a broad spectrum antibiotic that can inhibits 
almost all Gram-negative and Gram-positive bacteria. 
Tetracycline binds with the 30S subunit of ribosomes which 
inhibits the protein synthesis of the bacterial cells10,11.  This 
leads to the susceptibility of E. faecalis isolate to tetracycline.  
Penicillin or benzylpenicillin belongs to the β-lactams group 
of antibiotics in which it targets the cell wall synthesis. 
Penicillin-resistant bacteria resist the actions of β-lactams 
antibiotics by producing an enzyme called β-lactamase and 
penicillin-binding proteins12. Penicillin G or benzylpenicillin 
is active primarily against Gram-positive bacteria because 
the Gram-negative groups of bacteria are impermeable to β-
lactams group of antibiotics13. This could explain why E. 
faecalis was susceptible to β-lactams group of antibiotics 
specially at higher concentration. 
Erythromycin is a broad-spectrum antibiotic that targets the 
50S subunits of the bacterial ribosome that partially inhibits 
the protein synthesis. The partial inhibition of protein 
synthesis leads to the preferential translation of some 
proteins and restricts the translation of others that results to 
the imbalance of proteome which may consequently resulted 
to the disruption of metabolic process13.  
Chloramphenicol acts by inhibiting the 30S protein synthesis 
by disrupting the translation with the interactions of 
ribosomes often involving to ribosomal RNA (rRNA)13. 
Similar to the study of Franz et al.14, in which the study 
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reported that E. faecalis strains were mostly resistant to 
chloramphenicol.  
The aminoglycosides groups are composed of gentamicin, 
streptomycin and its derivatives, kanamycin and neomycin. 
This group of antibiotic target the 20S subunit of ribosomes, 
inhibiting the protein synthesis and are notably useful for the 
treatment of the Gram-negative group bacteria13. Natural 
resistance of anaerobic bacteria including Enterococcus spp. 
to aminoglycosides is due to the lack of oxidative metabolism 
to drive uptake of the antibiotics15,16. Low level of intrinsic 
resistance to aminoglycosides is mediated by the ability of 
the enterococcal cell wall to limit the uptake of the drug17. 
Another mechanism of high-level resistance to 
aminoglycosides is through the production of 
aminoglycosides-modifying enzymes which is common 
among enterococci. High-resistance to gentamicin is 
mediated by the functional enzyme 6'-aminoglycoside 
acetyltransferase 2″-aminoglycoside phosphotransferase 
[AAC(6')-Ie-APH(2″)-Ia]18. 
Wide spread use of antibiotics in aquaculture as prophylactic 
and therapeutic agents to bacterial diseases has been 
associated with the emergence of antibiotic resistance in 
bacterial pathogen and the alteration of the microbiota of 
aquaculture environment19,20. According to Kuhn et al.21, 
Enterococcus spp. is a good indicator of antimicrobial 
resistance in animals, human, and the environment including 
soil, manure, and water samples. They are known for the 
capability to acquire resistance determinants by rapid 
adaptation to environmental conditions. Resistance to 
antimicrobial drugs can arise either from new mutations in 
the bacterial genome or through the acquisition of genes 
encoding antibiotic resistance. These genetic changes 
consequently alter the defensive function of the bacteria by 
changing the target of the drugs, by detoxifying or ejecting 
the antimicrobial, or by routing metabolic pathways around 
the disrupted point21 
CONCLUSION 
The bacterium E. faecalis was susceptible to tetracycline as 
low as 20 μg/20 μl, and to penicillin and erythromycin 
starting at 60 μg/20 μl and 200 μg/20 μl, respectively. The 
bacterium was resistant to chloramphenicol even at the 
highest dosage of 400 μg/20 μl. Meanwhile, the bacterium 
was resistant to intermediate to gentamicin.  
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